Status:
COMPLETED
The Prevalence of HIV Drug Resistance and Transmission Risk in Opioid Agonist Treatment
Lead Sponsor:
Yale University
Conditions:
HIV Positive
Opioid Dependence
Eligibility:
All Genders
18-90 years
Brief Summary
HIV drug resistance presents a significant public heath problem. This proposal is designed to explore the association between ongoing illicit drug use and the prevalence of HIV drug resistance among H...
Eligibility Criteria
Inclusion
- HIV+
- Opioid dependent
- Receiving methadone or buprenorphine for at least one month
Exclusion
- age \< 18 years
- current dementia;
- inability to read or understand English
- inability to provide written informed consent
Key Trial Info
Start Date :
June 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2012
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT00857350
Start Date
June 1 2008
End Date
September 1 2012
Last Update
July 22 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Yale University Hospital
New Haven, Connecticut, United States, 06511